Key Takeaways
- SK Hynix achieved a $1 trillion valuation this week, marking only the second time a South Korean firm has reached this historic benchmark.
- Shares have skyrocketed 240% year-to-date, with gains exceeding 80% in May alone.
- First-quarter revenue surged nearly three times to 52.6 trillion won ($34.8bn), while operating profit jumped fivefold.
- The chipmaker commands 57% of the high-bandwidth memory (HBM) sector and secured roughly 70% of Nvidia’s Vera Rubin HBM supply contracts.
- American investors currently lack direct access, but the Roundhill Memory ETF (DRAM) — trading near $60 — allocates 27% to SK Hynix as its second-biggest holding.
SK Hynix entered an elite tier of global corporations this week, surpassing the $1 trillion market capitalization mark amid unprecedented AI-fueled appetite for advanced memory solutions.
SK hynix Inc. (000660.KS)The South Korean semiconductor manufacturer’s shares have climbed 240% since the start of the year, including an extraordinary 80%-plus gain throughout May — representing one of the most remarkable monthly performances for any large-cap company. By Friday’s close, its valuation stood at 1.66 quadrillion won, approximately $1.10 trillion.
The company becomes the third chip producer to achieve this benchmark this month, joining American giant Micron and domestic rival Samsung Electronics. These three organizations collectively dominate global memory chip manufacturing.
The catalyst is straightforward: AI infrastructure demands massive memory capacity. As appetite for GPUs and AI processing units has skyrocketed, so has demand for high-bandwidth memory (HBM) that enables them — with SK Hynix emerging as the primary winner.
Financial Performance Tells a Compelling Story
First-quarter revenue reached 52.6 trillion won ($34.8bn), representing a threefold increase year-over-year. Operating profit jumped fivefold to 37.6 trillion won ($24.9bn). Operating margins climbed to an unprecedented 72%.
These figures aren’t merely impressive — they’re transformational. HBM, a technology the company helped develop and continues to lead, has completely redefined its financial profile.
SK Hynix captured 57% of worldwide HBM sales in the fourth quarter of 2025, and projects maintaining over half the market for next-generation HBM4 throughout 2026. The firm has also locked in approximately 70% of HBM supply agreements for Nvidia’s Vera Rubin architecture, closely linking its trajectory to the industry’s dominant player.
Additionally, the company is executing multi-year supply contracts spanning three to five years — a fundamental change that should help stabilize the historically volatile memory market cycles.
Access Options for American Investors
SK Hynix shares aren’t currently available on US exchanges. While the company has submitted paperwork for American depositary receipts (ADRs) that may launch later this year, no timeline has been confirmed.
For now, the Roundhill Memory ETF (DRAM), trading between $60 and $63 per share, provides the most direct exposure. SK Hynix represents 27% of the fund’s holdings. Micron leads at slightly over 29%, with Samsung comprising 19%.
The fund also features NAND flash producers including Kioxia and Sandisk, alongside traditional storage companies like Seagate and Western Digital.
From a valuation perspective, SK Hynix trades at a forward P/E below 7 — remarkably modest for a company delivering such performance, though this partly reflects currency considerations and limited investor access.
SK Hynix anticipates DRAM supply constraints will persist through 2030, and is committing 19 trillion won ($13bn) toward a new fabrication facility focused on advanced packaging technology to meet accelerating demand.
Only 17 corporations throughout history have achieved a $1 trillion market value. SK Hynix now joins an exclusive group of just four non-American companies at this level, alongside Samsung, TSMC, and Saudi Aramco.
The post SK Hynix Crosses $1 Trillion Valuation After 240% Rally in 2025 appeared first on Blockonomi.






Be the first to comment